39th ECNP Congress: Program & Speakers
52 major sessions across 4 days with 149 confirmed speakers — the substantive program for 39th ECNP Congress, October 10–13, 2026 in Munich, Germany. Curated from the official program; excludes posters, exhibits, and social events.
Featured speakers: · · · · · · · · · · · · and 137 more below
No sessions match those filters. — or browse the full official program.
October 10, 2026
- KeynoteKL01 – Welcome, ECNP Awards Ceremony and Keynote Lecture 'Neural mechanisms of social homeostasis'
Opening keynote by Salk Institute neuroscientist Kay Tye on how neural circuits maintain social homeostasis and encode emotional valence.
- SymposiumS01 – Clinical trials across psychiatric disorders: the good, bad and the ugly
· · ·
Critical look at psychiatric trial design, generalizability, and digital therapeutics, including who gets excluded from RCTs.
- SymposiumS02 – Rhythms and blues – unravelling circadian-stress interactions in mental health
· · ·
How circadian clocks, stress systems, and the gut microbiome interact to shape mental health and sleep.
- SymposiumS03 – Breaking Hot Topic Symposium – showcasing the timeliest science – Altered immune function in psychiatric disorders and their treatment
· · · ·
Late-breaking findings on immune dysfunction in psychiatry, including the MEMOCYCLINE trial, microbiome-guided treatment, and immune-ageing phenotypes of depression.
- LectureE01 – Targeting the immune pathogenesis for the development of novel diagnostics and therapeutics of affective and non-affective psychosis
·
Educational update on immune-molecular patient stratification and multimodal inflammation measures in early psychosis.
October 11, 2026
- PlenaryPL01 – Protein monoaminylation in the brain: novel mechanisms of neural development, plasticity, and disease
Plenary on non-canonical roles of serotonin and other monoamines as direct protein modifications influencing gene expression and plasticity.
- PlenaryPL02 – ECNP Neuropsychopharmacology Award Lecture – How will we get novel medicines in psychiatry? Lessons from schizophrenia
Award lecture drawing lessons from schizophrenia drug development for the broader pipeline of novel psychiatric medicines.
- SymposiumS04 – Updates on bipolar disorder research: advancing translation into clinical practice
· · ·
Sex differences, genomics, lithium-response prediction (R-LiNK), and cognitive resilience in bipolar disorder.
- SymposiumS05 – Biomarker-based prediction and stratification in ADHD – where do we stand?
· · ·
Microbiota metabolites, inflammation, epigenetics, and polygenic risk as candidate stratification biomarkers in ADHD.
- SymposiumS06 – Retinal imaging in mental disorders: a novel lens on central nervous system dysfunction
· ·
Retinal neural and microvascular changes as accessible windows on CNS dysfunction in psychosis and autism.
- SymposiumS07 – Engineering mental health: targeted therapies to restore brain and brain-barrier function
· · ·
Blood-brain barrier biology as a therapeutic target, plus stem-cell-derived vesicles and focused ultrasound approaches.
- SymposiumS08 – Speech, digital phenotyping, and artificial intelligence in understanding and predicting trajectories and upcoming episodes in affective disorders
· · ·
NLP on health records, smartphone-based phenotyping, and machine learning to predict mood episodes and classify affective disorders.
- SymposiumS09 – Beyond borders: exploring the biological correlates of borderline personality disorder and implications for treatment
· · ·
Psychobiological models, peripheral molecular markers, REM sleep, and neuroimaging-treatment interactions in borderline personality disorder.
- LectureE02 – EPA Session – Improving psychiatric care in clinical practice: modern ways for treatment delivery
·
Joint EPA educational session on prevention, early intervention, and implementing digital psychiatry in routine care.
- LectureE03 – Advances in Tourette syndrome research
·
Update on childhood diagnosis and the neuropathophysiology and treatment of Tourette syndrome.
- SymposiumMS01 – Mini Symposium – Amyloid- and tau-PET biomarkers in late life depression: an update
·
PET biomarkers of amyloid, tau, and synaptic density in geriatric depression, including the Leuven L3D study.
- SymposiumMS02 – Proof-of-concept studies showcasing biomarker potential
·
Stratified precision-medicine trials, including an alpha-2a agonist for the cognitive biotype of depression and phase 2 results for the vasopressin 1b antagonist nelivaptan.
- LectureTP01 – Highlights in adult autism
Curated review of the year's most important papers on adult autism.
- LectureTP02 – Highlights in psychiatric genetics
Curated review of the year's top papers in psychiatric genetics.
- SessionPanel discussion – The innovation gap in mental health treatments – EU MIC
· · ·
Panel on Europe's lag in psychiatric drug innovation, access delays, and paths to bring pharmaceutical innovation back.
- SessionRS – Regulatory Spotlight Session – Metabolic risks of psychiatric medications: improving clinical safety through regulatory, industry, and academic insights
· ·
Academic, industry, and regulator perspectives on managing metabolic risks of psychotropic medications.
October 12, 2026
- PlenaryPL03 – Brain Prize Lecture – Malignant networks in the brain
Brain Prize lecture on how cancers integrate into and exploit neural networks.
- SymposiumS10 – Innovative approaches to understanding and treating anxiety disorders: from neurobiology to cutting-edge therapies
· · ·
Fear extinction mechanisms, genetics, next-generation anxiolytics, and digital/VR therapies for anxiety disorders.
- SymposiumS11 – The impact of early-life stress on brain development and psychopathology
· ·
Animal and cohort evidence on how early adversity and prenatal factors shape brain development and later psychopathology.
- SymposiumS12 – New Findings Symposium
· · · · ·
Six short talks on brand-new findings, from personalized rTMS targets in OCD to glymphatic function in depression and transcranial ultrasound stimulation.
- SymposiumS13 – The science of emotion regulation: integrating neuroscience, microbiome, and mindfulness
· · ·
- SymposiumS14 – Dysregulation of perineuronal nets, astrocytes and extrasynaptic transmission in neurodegeneration and mental disorders
· · ·
Extracellular matrix and perineuronal net biology as levers for reactivating plasticity in brain disease.
- SymposiumS15 – Novel Therapies Symposium – showcasing clinical trials on emerging compounds and new medical devices
· · · · ·
Trial results on emerging treatments including cannabidiol vs risperidone for cannabis-related psychosis (CANRISE), a novel oral NMDA antagonist, PDE10A inhibition in schizophrenia, and digital devices.
- LectureE04 – Chronic pain in mental health disorders – what do we know and where are we going?
·
Composite pain biomarkers and the neurobiology linking chronic pain with psychiatric comorbidity.
- LectureE05 – Computational psychiatry: promises and pitfalls
·
Critical appraisal of computational modelling in psychiatry and its path to mechanism-based treatments.
- CourseCS01 - ECNP Neuromodulation Course Session – from mechanisms to clinical application
· · ·
Interactive course working through difficult-to-treat OCD and depression cases with neuromodulation approaches.
- CourseCS02 – ECNP Child & Adolescent Psychiatry Course Session – from evidence-based care to precision approaches
·
Interactive course on evidence-based and precision approaches to child and adolescent psychiatry and neurodevelopmental disorders.
- CourseCS03 – ECNP Neuroscience Research course session – from preclinical validity to real-world impact
· · ·
Course on internal and external validity of preclinical data and communicating neuropsychopharmacology to the public.
- SymposiumMS03 – DSM Update Session – Future DSM diagnostic formulation: the promise of integrating dimensionality, biomarkers and transdiagnostic symptoms
·
APA speakers discuss how dimensional measures, biomarkers, and transdiagnostic symptoms could reshape future DSM formulations.
- SymposiumMS04 – EAN Mini Symposium – Rethinking the psychiatric approach in neurology conditions: in case of movement disorders
·
Joint neurology session on psychiatric management in Huntington's disease and Parkinson's disease psychosis.
- SymposiumMS05 – The Earth-Brain-Health Commission: aims, recommendations and impact
· ·
Presents the commission's recommendations on environment-brain-health interactions and global implementation.
- LectureTP03 – Highlights in women's mental health
Curated review of the year's top papers in women's mental health.
- LectureTP04 – Highlights in suicide
Curated review of the year's top papers in suicide research.
October 13, 2026
- PlenaryPL05 – Advancing mental health in a changing world: social context and biology
Plenary integrating social determinants and biological research in global mental health, from an East African vantage point.
- PlenaryPL06 – Virtual reality in youth mental health: evidence, applications and future directions
Plenary reviewing the evidence for VR-based assessment and treatment in youth mental health.
- SymposiumS16 – Cutting edge neuromodulation methods in brain disorders: methods, mechanisms and personalised targeting
· · ·
DBS, trigeminal nerve stimulation in ADHD, rTMS-augmented exposure therapy for OCD, and implantable VNS for difficult-to-treat depression.
- SymposiumS17 – Nature's shield: towards the neurobiology of resilience to psychiatric conditions
· · ·
Genetic, environmental, and clinical approaches to identifying resilience factors against psychiatric illness.
- SymposiumS18 – Closing the translational gap in addiction research: refining animal models for clinical impact
· · ·
How refined animal models of alcohol, nicotine, and cannabis use can better inform addiction treatment.
- SymposiumS19 – Bridging preclinical and clinical findings in psychedelic research – translational advances in psychedelic research
· · ·
Psilocybin and ketamine effects on neurogenesis, synaptic plasticity, and the role of setting, from bench to PET imaging.
- SymposiumS20 – How can artificial intelligence transform mental health research?
· · ·
Multimodal AI for patient stratification, generative AI for symptom extraction, and algorithmic fairness in clinical neuroscience.
- SymposiumS21 – Neurobiology and clinical translation of treatment resistance in major psychiatric disorders
· · ·
iPSC models, pharmacogenomics, ECT cognitive effects, and lived-experience perspectives on treatment resistance.
- SymposiumS22 – Excess mortality in people with mental health problems – influence of comorbidity
· · ·
Evidence on premature mortality in anxiety, bipolar disorder, and schizophrenia, and the role of physical comorbidity and inflammation.
- LectureE06 – The arts and mental health
·
Arts-based strategies and the translation of music therapy into clinical mental health practice.
- LectureE07 – Long-term effects of ADHD medication: new evidence from real-world data
·
Real-world evidence on long-term academic outcomes and the safety of methylphenidate in children.
- LectureTP05 – Highlights in obsessive-compulsive and related disorders
Curated review of the year's top papers in OCD and related disorders.
- LectureTP06 – Highlights in old age
Curated review of the year's top papers in old-age psychiatry.
- SessionPanel discussion – Artificial intelligence in mental health – Progress and perils
· · ·
The ECNP AI in Mental Health network presents its European implementation effort, followed by a panel on limitations and risks of current AI systems.
Never miss an early-bird deadline
One-click alerts for this conference — we email you 14 and 3 days before each deadline:
- Conference starts — October 10, 2026
Browse the directory
By date
By specialty
- General Psychiatry
- Psychopharmacology
- Child & Adolescent Psychiatry
- Addiction Psychiatry
- Geriatric Psychiatry
- Forensic Psychiatry
- Consultation-Liaison Psychiatry
- Anxiety & Depression
- Neuroscience
- Psychiatric Nursing / PMHNP
- ADHD
- Bipolar Disorders
- Schizophrenia & Psychosis
- Trauma & PTSD
- Women's & Perinatal Mental Health
- Psychotherapy
- Emergency Psychiatry
- Interventional Psychiatry & Neuromodulation
- Psychedelic Medicine
- Suicide Prevention
- OCD & Related Disorders
- Autism Spectrum
- Sleep Medicine
By location
- International
- Midwest US
- Northeast US
- Southern US
- Western US
- California (6)
- Colorado (4)
- San Diego (4)
- Boston (3)
- Chicago (3)
- Denver (3)
- Illinois (3)
- Massachusetts (3)
- Texas (3)
- Washington (3)
- Washington, D.C. (3)
- Arizona (2)
- Atlanta (2)
- Canada (2)
- Cape Town (2)
- Florida (2)
- Georgia (2)
- Hawaii (2)
- Louisiana (2)
- New Orleans (2)
- New York (2)
- New Zealand (2)
- South Africa (2)
- Tennessee (2)
- Albuquerque (1)
- Asheville (1)
- Auckland (1)
- Austin (1)
- Baltimore (1)
- Brazil (1)
- Christchurch (1)
- Colorado Springs (1)
- Dallas (1)
- Florence (1)
- France (1)
- Germany (1)
- Glasgow (1)
- India (1)
- Italy (1)
- Jaipur (1)
- Kapolei (1)
- Kentucky (1)
- Koloa (Kauai) (1)
- Lake Buena Vista (1)
- Las Vegas (1)
- Louisville (1)
- Lyon (1)
- Maryland (1)
- Memphis (1)
- Montreal (1)
- Munich (1)
- Napa (1)
- Nashville (1)
- Nevada (1)
- New Mexico (1)
- Newport Beach (1)
- North Carolina (1)
- Phoenix (1)
- Reston (1)
- Rio de Janeiro (1)
- San Antonio (1)
- Scottsdale (1)
- Stockholm (1)
- Sweden (1)
- Tampa (1)
- United Kingdom (1)
- Vancouver (1)
- Virginia (1)